Ractigen Therapeutics Announces Dosing of First Patient in First in Human Trial of RAG-17 for the Treatment of SOD1-ALS
Study aims to evaluate the safety and feasibility of RAG-17 in human patients and clinically…
ractigenJune 10, 2023
